{'fraction_non_alphanumeric': 0.03185063152114223, 'fraction_numerical': 0.020318506315211423, 'mean_word_length': 4.784126984126984, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
C-peptide decline in type 1 diabetes has three phases in patients with partial remission.

AIMS
To explore the different patterns of C-peptide decline in patients with and without partial remission of newly diagnosed type 1 diabetes.


MATERIALS AND METHODS
A total of 298 patients with new-onset type 1 diabetes were followed up regularly at 3 months' interval to investigate the loss of C-peptide. Partial remission was determined by postprandial C-peptide ≥300 pmol/L or insulin dose-adjusted A1c ≤9 in the absence of C-peptide. Beta-cell function was defined as preserved, residual, or failed by postprandial C-peptide of ≥200 pmol/L, 50-200 pmol/L, or ≤50 pmol/L, respectively.


RESULTS
Altogether, 199 out of 298 patients (125 adults) had partial remission. The pattern of C-peptide change in patients with partial remission was three-phasic, demonstrating an upward trend followed by a downward trend of fast first and then slow, while the pattern in patients without partial remission was biphasic, showing an initial fast fall and a subsequent slower decrease. The patterns remained consistent when patients were stratified by the age of onset. At 3 years, there were 71% of the patients with partial remission still had preserved or residual beta-cell function, while 89% of the patients who had no partial remission developed beta-cell function failure. In patients whose partial remission ended, the average C-peptide was still higher than duration-matched patients without partial remission.


CONCLUSIONS
Patients with partial remission of type 1 diabetes are shown to have a distinct three-phasic pattern of C-peptide decline, other than the widely recognized biphasic pattern. The effects of partial remission still exist after remission ends. This article is protected by copyright. All rights reserved.